|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Chronic ac- quired hepatocerebral degeneration, effects of liver trans- plantation on neurological manifestations 显示文摘 | STRACCIARI A BALDIN E CRETELLA L | 2011 | Neurol Sci2011，32，3： | 1 |
| 2 | Solar-grade Silicon显示文摘 | Bathey B R Cretella M C | | 0，，11： | 1 |
| 3 | Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder显示文摘 | Van Dyck C H Quinlan D M Cretella L M | 2002 | Am J Psychiatry2002，159，2： | 1 |
| 4 | Chronic acquired hepa- tocerebral degeneration: effects of liver transplantation on neuro- logical manifestations显示文摘 | Stracciari A Baldin E Cretella L | 2011 | Neurol Sci2011，32，3： | 1 |
| 5 | Late onset bipolar disor- der due to a lacunar state 显示文摘 | Antelmi E Fabbri M Cretella L | 2014 | Behav Neurol2014，2014，： | 1 |
| 6 | 局部注射英夫利昔单抗治疗克罗恩病的术后复发显示文摘Background: Local injection of infliximab in Crohn’s disease (CD) lesions may reduce the risk of rare side effects, reduce the dose, and increase the efficacy of the drug. The objective was to prospectively assess the feasibility and the safety of local injection of infliximab for the postoperative recurrence of patients with CD who were followed for at least 1 year. Methods: In a pilot, open-label study, 8 patients with CD (3 men; median age 48 years, range 35- 82 years) undergoing ileocolonoscopy were prospectively enrolled. Inclusion criteria included the following: (1) localized (< 5 cm) recurrence, (2) inflammatory pattern, and (3) clinically inactive CD. At the first endoscopy, lesions were injected with infliximab (median, 30 mg; range, 8- 60 mg); a control endoscopy was performed at 2 weeks in 4 patients (3 received a second injection followed by a control endoscopy at 6 weeks) and at 4 weeks in 4 patients (2 received a second injection followed by a control endoscopy at 8 weeks). Observations: No patients showed side effects or clinical relapse in the short term and the long term (median follow-up, 20 months; range, 14- 21 months). Endoscopic score improved in 3/8 patients. The histologic scores were reduced in 4 patients, worsened in 3, and were unchanged in one patient with CD. Conclusions: Local injection of infliximab into patients with CD recurrence is feasible and safe, requiring a low dose. Present findings suggest the need of placebo-controlled trials to assess the efficacy of this new and safe procedure in subgroups of patients with CD. | Biancone L. Cretella M. Tosti C. 王晓君(译) 郑世成(校) | 2006 | 世界核心医学期刊文摘(胃肠病学分册)2006，2，8： | 1 |
| 7 | Solar-grade silicon显示文摘 | B. R. Bathey M. C. Cretella | 1982 | Journal of Materials Science1982，，11： | 1 |
| 8 | Chronic acquiredhepatocerebral degeneration:effects of liver transplantationon neurological manifestations显示文摘 | Stracciari A Baldin E Cretella L | 2011 | Neurol Sci2011，32，3： | 1 |
| 9 | Chronic acquired hepa- tocerebral degeneration:effects of liver transplantation on neu- rological manifestations显示文摘 | Stracciari A Baldin E Cretella L | 2011 | Neurol Sci2011，32，3： | 1 |
| 10 | Solar-grade silicon显示文摘 | B. R. Bathey M. C. Cretella | 1982 | Journal of Materials Science1982，，11： | 1 |
| 11 | 显示文摘 | Bathey B R Cretella M C | 1982 | Journal of Materials Science1982，17，： | 1 |
| 12 | Local injection of infliximab in the postoperative recurrence of Crohn's disease显示文摘 | Biancone L Cretella M Tosti C | 2006 | Gastrointest Endosc2006，63，： | 1 |
| 13 | Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and over- comes gefitinib resistance显示文摘 | Cretella D Saccani F Quaini F | 2014 | Mol Cancer2014，13，： | 1 |
| 14 | Chronic acquired hepa- tocerebral degeneration: effects of liver transplantation on neuro- logical manifestations显示文摘 | Stracciari A Baldin E Cretella L | 2011 | Neurol Sci2011，32，3： | 1 |
| 15 | Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance显示文摘 | Cretella D Saccani F Quaini F | 2014 | Mol Cancer2014，13，143： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员